News | August 01, 2023
Concord Biotech’s IPO to open on 4th August, 2023
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
1. 10 crore teleconsultations have been rendered to senior citizens and 5,22,15,224 to women
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
Advances clinical research capabilities with leading regulatory grade registries platform
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
The booster vaccine can be administered safely to individuals who have received two doses of either Covaxin or Covishield
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Subscribe To Our Newsletter & Stay Updated
